Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Dec 3, 2024. (Total: 234028Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 7 (of 7 Records)

Query Trace: Overdose and CYP2C9[original query]
Genetic and environmental risk factors for oral anticoagulant overdose.
European journal of clinical pharmacology 2003 Mar 58 (11): 739-45.
Verstuyft C, Robert A, Morin S, Loriot M A, Flahault A, Beaune P, Funck-Brentano C, Jaillon P, Becquemont
Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity.
Blood 2005 Jul 106 (1): 135-40.
Bodin Laurent, Verstuyft Céline, Tregouet David-Alexandre, Robert Annie, Dubert Liliane, Funck-Brentano Christian, Jaillon Patrice, Beaune Philippe, Laurent-Puig Pierre, Becquemont Laurent, Loriot Marie-An
Frequency of selected single nucleotide polymorphisms influencing the warfarin pharmacogenetics in Slovak population.
European journal of haematology 2014 Oct 93 (4): 320-8.
Kraj?íová L'ubica, Petrovi? Robert, Déžiová L'udmila, Chandoga Ján, Tur?áni Pet
Frequencies of polymorphisms in CYP2C9 and VKORC1 genes influencing warfarin metabolism in Slovak population: implication for clinical practice.
Bratislavské lekárske listy 2014 115 (9): 563-8.
Krajciova L, Deziova L, Petrovic R, Luha J, Turcani P, Chandoga
CYP2C9 and VKORC1 in therapeutic dosing and safety of acenocoumarol treatment: implication for clinical practice in Hungary.
Environmental toxicology and pharmacology 2017 Oct 56 282-289.
Varnai Reka, Sipeky Csilla, Nagy Lajos, Balogh Sandor, Melegh Be
Correlation between CYP2C9 gene polymorphism and warfarin dose in Chinese Han population with coronary heart disease.
Cellular and molecular biology (Noisy-le-Grand, France) 2021 Dec 67 (5): 157-163.
Zuo Qiyu, Li Li, Zhong Mingjing, Chen Gengbiao, Xio Junh
Warfarin Dosing in Patients With CYP2C9*5 Variant Alleles.
Clinical pharmacology and therapeutics 2022 Feb .
Lindley Kathryn J, Limdi Nita A, Cavallari Larisa H, Perera Minoli A, Lenzini Petra, Johnson Julie A, Wu Alan H B, Ridker Paul M, King Cristi R, Eby Charles S, Patel Shitalben, Shah Shimoli V, Beasley T Mark, Li Juan, Gage Brian
TOP